5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The UK ophthalmology devices market is segmented by Devices (Surgical Devices, Diagnostic and Monitoring Devices, and Vision Correction Devices).
Ophthalmology Device Market in the United Kingdom is expected to grow, due to the rising number of eye-related diseases and disorders, and greater awareness among people. According to the Royal National Institute of Blind People, as of 2017, there are around 350,000 people on the registers of blind and partially sighted people in the UK. A total of 173,735 are registered severely sight impaired and 176,125 are registered sight-impaired.
Further, the development of new ophthalmology devices and advanced techniques are favouring the growth of the market. Although the ophthalmology devices market displays great promise, due to the increasing number of eye problems, it still faces barriers, such as the risk associated with surgical procedures of the eye which might impede the growth of the market.
Ophthalmology is a branch of medical sciences, which deals with structure, function, and various diseases related to eye. The ophthalmic devices based on the product function are majorly categorized into surgical, diagnostic, and vision correction devices.
Report scope can be customized per your requirements. Click here.
To understand key trends, Download Sample Report
UK Ophthalmology Devices is highly fragmented owing to the presence of more number of market players. Market players focus on continuous product development and offering OphthalmologyDevices at competitive prices especially in developing countries. The major players include Abbott, Alcon, Johnson & Johnson Vision Care Inc., Cooper Vision Inc., Bausch & Lomb, Carl Zeiss AG, Topcon Corporation, Nidek Co. Ltd.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Demographic Shift and Increasing Prevalence of Eye Diseases
4.2.2 Technological Advancements in Ophthalmic Devices
4.3 Market Restraints
4.3.1 Risk Associated with Ophthalmic Procedures
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Devices
5.1.1 Surgical Devices
220.127.116.11 Glaucoma Drainage Devices
18.104.22.168 Glaucoma Stents and Implants
22.214.171.124 Intraocular Lenses
126.96.36.199 Other Surgical Devices
5.1.2 Diagnostic and Monitoring Devices
188.8.131.52 Autorefractors and Keratometers
184.108.40.206 Corneal Topography Systems
220.127.116.11 Ophthalmic Ultrasound Imaging Systems
18.104.22.168 Optical Coherence Tomography Scanners
22.214.171.124 Other Diagnostic and Monitoring Devices
5.1.3 Vision Correction Devices
126.96.36.199 Contact Lenses
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Alcon Inc.
6.1.2 Bausch Health Companies Inc.
6.1.3 Carl Zeiss Meditec AG
6.1.4 HAAG-Streit Group
6.1.5 IRIDEX Corporation
6.1.6 Johnson and Johnson
6.1.7 Nidek Co. Ltd
6.1.8 Topcon Corporation
6.1.9 Ziemer Ophthalmic Systems AG
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments